According to morphological studies, NMMHC-IIA localizes in the podocyte cell body and primary processes; diminished expression of the latter was observed in primary focal segmental glomerulosclerosis, minimal change disease, and in a mouse puromycin aminonucleoside nephropathy model of acquired podocyte injury [40]. This evidence concerns the gene MYH9 and kidney disorder.